Enhancing Caudal Analgesia in Children: A Narrative Review of Clonidine and Dexmedetomidine as Adjuvants

Caudal epidural analgesia is a common method of pediatric anesthesia for infraumbilical and lower limb operations. Despite being useful, the limited duration of action of local anesthetics by themselves necessitates the addition of adjuvants to prolong postoperative pain relief. Among them, clonidine and dexmedetomidine, both α2-adrenergic agonists, have become popular because of their analgesic-sedative effects in combination. This review discusses the pharmacology, clinical efficacy, safety, and comparison of dexmedetomidine and clonidine as adjuvants for pediatric caudal blocks. Randomized controlled trials, meta-analyses, and systematic reviews were used in combination to compare their roles. The significant outcomes are quality and duration of analgesia, hemodynamic stability, sedation, and side effects. Both drugs significantly prolong the duration of caudal analgesia, reduce postoperative opioid consumption, and exhibit good safety profiles. Dexmedetomidine gives better pain relief and enhanced sedation due to its greater α2-receptor selectivity but also poses a higher risk for bradycardia and hypotension. Clonidine, though less potent, shows consistent effectiveness, is cost-efficient, and has a safer hemodynamic profile, making it especially suitable for outpatient procedures. Clonidine and dexmedetomidine are effective adjuvants for enhancing pediatric caudal analgesia. While dexmedetomidine is better for longer and more painful surgeries, clonidine offers a balanced option when quick recovery and stable blood pressure are priorities. Future large-scale studies and long-term neurodevelopmental safety research are necessary to optimize their clinical use.